Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Nov-24 6:23 PM View:  | Equillium, Inc. (EQ) | 14-Nov-24 | Sale (Planned) | 10,000 | $0.70 | $7,000.00 | (8%) 131.63K to 121.63K | |
| 27-Sep-24 7:38 PM View: | Equillium, Inc. (EQ) | 26-Sep-24 | Sale (Planned) | 10,000 | $0.81 | $8,100.00 | (7%) 141.63K to 131.63K | |
| 18-Jul-24 5:52 PM View: | Equillium, Inc. (EQ) | 16-Jul-24 | Sale (Planned) | 10,000 | $0.87 | $8,700.00 | (7%) 151.63K to 141.63K | |
| 03-Jan-24 6:10 PM View: | Equillium, Inc. (EQ) | 08-Dec-23 | Grant | 8,805 | $0.58 | $5,106.90 | 7% 127.83K to 136.63K | |
| 03-Jan-24 6:10 PM View: | Equillium, Inc. (EQ) | 09-Jun-23 | Grant | 15,000 | $0.56 | $8,400.00 | 13% 112.83K to 127.83K | |
| 04-Jan-23 6:50 PM View: | Equillium, Inc. (EQ) | 09-Dec-22 | Grant | 4,444 | $1.19 | $5,288.36 | 4% 108.38K to 112.83K | |
| 30-Aug-22 5:57 PM View: | Equillium, Inc. (EQ) | 29-Aug-22 | Sale (Planned) | 7,000 | $2.83 | $19,810.00 | (6%) 115.38K to 108.38K | |
| 24-Jun-22 6:29 PM View: | Carisma Therapeutics Inc. (CARM) | 22-Jun-22 | Grant | 40,000 | -- | -- | 100% 0 to 40.0K | |
| 06-Jun-22 9:17 PM View: | Equillium, Inc. (EQ) | 06-Jun-22 | Sale (Planned) | 5,000 | $2.52 | $12,600.00 | (4%) 113.02K to 108.02K | |
| 05-Apr-22 5:40 PM View: | Equillium, Inc. (EQ) | 04-Apr-22 | Market Sale (Planned) | 8,000 | $3.18 | $25,440.00 | (7%) 121.02K to 113.02K | (9%) |
| 13-Dec-21 10:01 AM View: | Equillium, Inc. (EQ) | 10-Dec-21 | Grant | 5,585 | $2.35 | $13,124.70 | 5% 115.43K to 121.02K | |
| 03-Dec-21 1:57 PM View: | Equillium, Inc. (EQ) | 01-Dec-21 | Market Sale (Planned) | 5,000 | $5.08 | $25,401.50 | (4%) 120.43K to 115.43K | 7% |
| 29-Sep-21 1:02 PM View: | Equillium, Inc. (EQ) | 27-Sep-21 | Market Sale (Planned) | 8,000 | $6.74 | $53,924.00 | (6%) 128.43K to 120.43K | 1% |
| 28-Jul-21 11:55 AM View: | Equillium, Inc. (EQ) | 27-Jul-21 | Market Sale (Planned) | 5,000 | $5.72 | $28,585.00 | (4%) 133.43K to 128.43K | (2%) |
| 14-Jun-21 5:56 PM View: | Equillium, Inc. (EQ) | 10-Jun-21 | Grant | 5,535 | $2.35 | $13,007.20 | 45% 12.18K to 17.71K | |
| 28-May-21 6:20 PM View: | Equillium, Inc. (EQ) | 26-May-21 | Market Sale (Planned) | 5,000 | $6.50 | $32,483.50 | (4%) 120.72K to 115.72K | (4%) |
| 28-Dec-20 9:15 AM View: | Equillium, Inc. (EQ) | 23-Dec-20 | Market Sale (Planned) | 8,000 | $4.74 | $37,913.60 | (6%) 140.9K to 132.9K | 2% |
| 11-Dec-20 5:00 PM View: | Equillium, Inc. (EQ) | 10-Dec-20 | Acquisition (other) | 5,362 | $2.35 | $12,600.70 | 4% 135.53K to 140.9K | |
| 12-Jun-20 4:30 PM View: | Equillium, Inc. (EQ) | 10-Jun-20 | Acquisition (other) | 5,014 | $2.41 | $12,083.70 | 4% 130.52K to 135.53K | |
| 19-Feb-20 5:48 PM View: | Equillium, Inc. (EQ) | 18-Feb-20 | Market Sale (Planned) | 5,000 | $5.03 | $25,137.50 | (4%) 135.52K to 130.52K | 6% |
| 22-Jan-20 8:13 PM View: | Equillium, Inc. (EQ) | 21-Jan-20 | Market Sale (Planned) | 5,000 | $4.41 | $22,043.00 | (4%) 140.52K to 135.52K | (7%) |
| 04-Sep-19 5:35 PM View: | Equillium, Inc. (EQ) | 03-Sep-19 | Market Sale (Planned) | 5,000 | $3.60 | $17,980.50 | (3%) 143.72K to 138.72K | (30%) |
| 05-Aug-19 5:04 PM View: | Equillium, Inc. (EQ) | 01-Aug-19 | Market Sale (Planned) | 5,000 | $3.99 | $19,941.00 | (3%) 148.72K to 143.72K | (18%) |
| 02-Jun-17 4:44 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 31-May-17 | Grant | 557 | $1.55 | $863.35 | 23% 2.47K to 3.03K | |
| 02-Dec-16 5:10 PM View: | Orexigen Therapeutics, Inc. (OREXQ) | 30-Nov-16 | Grant | 291 | $1.67 | $485.97 | 13% 2.18K to 2.47K |